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Background: Extrapulmonary tuberculosis (EPTB) constitutes
about 15% to 20% of all cases of tuberculosis (TB). The con-
firmation of EPTB has always been a challenge to laboratory
personnel. We aim to evaluate the diagnostic potential of im-
munostaining with anti-MPT64 in various EPTB specimens.
Materials and Methods: We studied a total of 51 TB cases and 38
non-TB control specimens comprising of fine-needle aspirates and
formalin-fixed biopsies. These were investigated using a combi-
nation of the Ziehl-Neelsen method, the Lowenstein-Jensen cul-
ture, immunostaining with anti-MPT64 and anti-BCG, and
nested-polymerase chain reaction (PCR) for IS6110. Results of all
the tests were compared using nested-PCR as the gold standard.
Results: Diagnostic validation of immunostaining for anti-
MPT64 was performed using nested-PCR as the gold standard.
The overall sensitivity, specificity, and positive and negative
predictive values for immunostaining with anti-MPT64 were
100%, 97%, 97%, and 100%, respectively.
Conclusions: Immunostaining using anti-MPT64 is a rapid
and sensitive method for establishing an early and specific
diagnosis ofMycobacterium tuberculosis infection. The technique
is simple to be incorporated into routine pathology laboratories.
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BACKGROUND
Extrapulmonary tuberculosis (EPTB) has been a
major cause of suffering from time immemorial. Any
organ system in the body can be affected by tuberculosis
(TB). Molecular genetic evidence of infection with the
Mycobacterium tuberculosis complex is available in
Egyptians mummies in the form of Pott’s spine.1 EPTB
constitutes about 15% to 20% of all cases of TB with a
wide variability range (4% to 48%) among the reporting
countries of notified TB cases.2–4 Its annual global
incidence has been increasing in the last decade due to the
changing TB control practices, the population growth,
and the spread of human immunodeficiency virus (HIV).
The rate of EPTB is reported to be >50% in patients
with HIV coinfection.5
The diagnosis of EPTB has always been a problem
for clinicians. As per WHO, the diagnosis of EPTB
should be made on the basis of a culture-positive speci-
men or caseating granuloma on biopsy or strong clinical
evidence consistent with active EPTB.6 However, it is
difficult to demonstrate M. tuberculosis with routine
techniques such as culture and staining for acid-fast ba-
cilli (AFB) due to the pauci-bacillary nature of EPTB. In
35% to 65% of the patients with EPTB, Ziehl-Neelsen
(ZN) staining7 or Lowenstein-Jensen (LJ) culture are
negative. Also, the results of the tests assessing TB
infection such as tuberculin skin test or interferon-gamma
release assays may be misleading.8 Secondly, routine cy-
tology and histology cannot distinguish between the dis-
eases caused by TB or non-TB mycobacterium, or chronic
inflammatory conditions. TB, thus, remains undiagnosed
in 20% cases even after multiple biopsies or aspira-
tions.9–11 Furthermore, EPTB is difficult to diagnose due
to the extremely wide clinical presentation depending on
the organ affected, the disease stage, and the immune
response of the host. Most often, the possibility of EPTB
is lately put into the differential diagnosis during the
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evaluation of a patient. The EPTB diagnosis is thus most
often made by the integration of several nonspecific re-
sults from various investigations. The need to perform
invasive techniques for most of the EPTB cases to obtain
specimens further complicates the diagnostic protocol of
EPTB. In the past decade, newer techniques such as ra-
diometric and nonradiometric assays together with im-
proved molecular methods for identifying M. tuberculosis
have an improved diagnostic capacity, but the use of these
techniques in resource-constrained settings where TB re-
mains an important public health problem is limited. The
decision for an empirical course of antibiotic treatment in
this situation, thus, often precedes evidence-based diag-
nosis.These problems highlight the need for an improve-
ment in the diagnostic methods of EPTB.
We previously described the use of immunostaining
to detect M. tuberculosis complex-specific mycobacterium
antigen MPT64 from lymph node fine-needle aspirates
and biopsies from tuberculous lymphadenitis, abdominal
TB, and tuberculous pleural, ascitic, and cerebrospinal
fluids.12–14 Immunostaining using anti-MPT64 showed a
high specificity (95%) and sensitivity (85%).12,13 The
technique is robust and yields consistent results in dif-
ferent settings and in HIV patients.14,15 The aim of this
study was to extend the previously published research by
testing the diagnostic potential of immunostaining using
anti-MPT64 on additional sites of EPTB, and extension
of the method to the lesser invasive sampling procedure of
fine-needle aspirates from different sites.
MATERIALS AND METHODS
Patients and Specimens
The study was performed at Ujjain Charitable
Hospital, Ujjain, India, from July 2007 to March 2010.
Fine-needle aspirate smears and surgical biopsies were
collected from the Department of Pathology. Detailed
clinical results were obtained from the patients or from the
records. Surgical biopsies from non-TB (control)
lesions were also obtained from the Department of Path-
ology, Haukeland University Hospital, Bergen, Norway.
Two known pulmonary TB biopsy specimens from the
archive with a high bacterial load were used as known
positive controls. The diagnostic categories included are
shown in Table 1. The collected specimens were processed
for ZN stain, LJ culture (not for all biopsies), cytology or
histology examination, immunostaining with anti-BCG
and anti-MPT64, and nested-polymerase chain reaction
(PCR) for IS6110. The final diagnosis of TB was estab-
lished on the fulfillment of one of the following criteria:
the presence of AFB on ZN stain and/or M. tuberculosis
on culture and/or positive IS6110-based nested-PCR.
Specimens were classified as non-TB when all the above-
mentioned criteria were negative. Biopsies or aspirates
from patients with pulmonary TB, patients below 14 years
of age, and those on corticosteroid therapy or on im-
munosuppressive therapy were excluded from the study.
The decision for aspiration or biopsy was based on
the clinical necessity and not for the sake of participation
in the study. Informed written consent was obtained from
the patients, and the patients were ensured of con-
fidentiality. Ethical approval was obtained from the In-
stitutional ethical committee at Ujjain Hospital and the
regional ethical committees in both Norway and India.
The performance indices (the sensitivity, the specificity,
and the positive and negative predictive values) were
calculated and compared on an accuracy matrix.
Fine-Needle Aspirate and Biopsy
Fine-needle aspiration from mass was performed
under sterile condition using a 22-G needle. One part of
the aspirate was sent for culture and the other part was
used for preparing multiple smears. The slides were air
dried, and stained with May-Grunwald-Giemsa stain for
cytological examination, ZN staining, and 3 to 5 smears
were ethanol fixed and used for PCR and immunostain-
ing. On microscopic examination, the cytological findings
were classified according to the amount of necrosis, the
type of cells and their arrangement into necrotic gran-
ulomas, necrotic material showing mainly degenerated
neutrophils, lymphocytes, and epithelioid cells, and non-
necrotic granulomas.13
The biopsies were fixed in 4% phosphate-buffered
formaldehyde for conventional paraffin embedding, followed
by hematoxylin-eosin and ZN staining by the heat carbol
fuschin method. Subsequent sections were collected on 3
special capillary gap slides (Dako A/S, Denmark) for im-
munostaining and 5 to 6 thick sections in Eppendorf tubes
for PCR. Contamination was prevented by cleaning the
blade with 96% ethanol after sectioning each sample; neg-
ative controls were sectioned first, followed by test blocks
and positive control blocks. The biopsy sections were ex-
amined for the presence and the type of epitheloid gran-
ulomas (well-organized and nonorganized) and the presence
or the absence of necrosis.12 A part of the specimen was sent
for mycobacterial culture on LJ media before formalin fix-
ation. Some biopsies were, however, not sent for culture.
Immunostaining
Immunostaining was performed using the Dako kit
(EnVision+System-HRP; Dako, Glostrup, Denmark) on
all the smears from the aspirates and the tissue sections to
demonstrate the presence of mycobacterial antigens
MPT64 and BCG as described in detail previously.12,13 In
brief, the alcohol-fixed aspirate smears were hydrated
through decreasing grades of alcohol, and washed in
phosphate-buffered saline.13 For biopsy, tissue sections
were first deparaffinized and hydrated; then, microwave
antigen retrieval using citrate buffer, pH 6.2, at 750W for
10 minutes, and at 350W for 15 minutes was performed.
The sections were cooled at room temperature for 20 mi-
nutes. All the slides (aspirate and biopsy) were then in-
cubated with hydrogen peroxide for 5 minutes. to inhibit
the endogenous peroxidase activity, followed by in-
cubation with primary antibodies: (i) rabbit polyclonal
anti-BCG (Dako, Hamburg, Germany) at 1/5000 dilution
for 1 hour after treating the sections with 3% bovine se-
rum albumin for 3 minutes; (ii) in-house rabbit polyclonal
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absorbed anti-MPT64 antibody at 1/250 dilution for 1
hour. Anti-MPT64 was absorbed with an MPT64-non-
producing BCG strain as detailed previously to remove
cross-reactive antibodies.15 The bound antibodies were
recognized with a secondary antibody anti-rabbit dextran
polymer conjugated to horseradish peroxidase for 45 mi-
nutes. Positive signals were visualized as reddish brown
with a 3-amino-9-ethylcarbazol and hydrogen peroxide-
containing substrate and counterstained with Harris
hematoxylin for 1 minute; slides were then mounted in an
aqueous immunomount (Sigma Chemical) for micro-
scopy. All incubations were carried out at room temper-
ature, and the sections were washed thoroughly with
0.05M trisbuffered saline-tween 20 between incubations.
In every experiment, 1 positive and 2 negative controls [in
one the primary antibody was substituted with antibody
diluents and in the other an irrelevant rabbit polyclonal
antibody (anti-HCG) was used to evaluate the specificity
of the reaction] were included. The intensity of staining
was evaluated and categorized as weak, moderate, and
strong staining on the basis of subjective assessment.
Nested-PCR Assay
The DNA extraction procedure was followed as de-
scribed in detail previously for biopsy and aspirates.16 For
aspirates, in brief, with “wet-scratching,” the smears were
treated with 100mL of proteinase K in tris-EDTA digestion
buffer and the washing was collected in an eppendorf tube,
which was treated with the slurry of acid-washed RNase-free
zirconium-silica ceramic beads of 0.5g of 0.1mm diameter and
then processed in the Hybaid Ribolyser shaker. The sample
was incubated at 801C for 20 minutes and centrifuged at 5000g
for 2 minutes. The supernatant was used for PCR amplifica-
tion or it was stored at 201C until use. For biopsy, the
deparaffinization, the digestion, and the extraction of DNA
was performed as per the procedure described previously.12,16
From each specimen, the extracted DNA was amplified in
triplicate by nested-PCR for a 123-base pair fragment from
IS6110 in the first round of the reaction with the primer of
coding sequence 50CCTGCGAGCGTAGGCGTCGG30 and
50CTCGTCCAGCGCCGCTTCGG30. The amplified prod-
uct served as a template for a second round of PCR to amplify
a 92-base pair fragment with the primers of the coding se-
quence 50TTCGGACCACCAGCACCTAA30 and 50TCGG
TGACAAAGGCCACGTA30 as mentioned previously in
detail.12 The PCR mix consisted of 5mL eluted DNA+25mL
of HotStarTaq master mix (Qiagen, West Sussex, UK)+
0.25mL of each 100mM primer stock solution+distilled water
to make a final volume of 50mL. For nested-PCR, 1mL of first
PCR product was used as the template. Positive and negative
controls and random sample retest were processed in all the
PCR assays.
RESULTS
A total of 89 specimens (52 aspirates and 37 biop-
sies) with a confirmed diagnosis of either TB (n=51) or
non-TB (n=38) were analyzed in the study (Table 1).
Non-TB specimens were chronic nonspecific lymphade-
nitis (n=29) biopsies showing fungal (n=2) and para-
sitic granuloma (n=2) and malignancy (n=5).
AFB Microscopy, Culture, and PCR
AFB were detected by ZN staining in 05/51 (10%)
specimens and M. tuberculosis was cultured in 12/40
(30%) TB specimens. PCR, ZN staining, and culture were
negative in all non-TB specimens. Nested-PCR was per-
formed for comparison and to calculate the diagnostic
indices of immunostaining.
Microscopy
Biopsies revealed either well-organized and/or
poorly organized granulomas, whereas the smears showed
TABLE 1. The Performance of Diagnostic Tests on Various Tuberculosis Specimens (N = 51)
No. Specimens Positive by
Tuberculosis Specimens Lowenstein-Jensen Culture Ziehl-Neelsen Stain Staining With Anti-BCG Staining With Anti-MPT64
Aspirate
Pleural mass (n=4) 2 0 4 4
Lung mass (n=3) 1 0 3 3
Renal mass (n=2) NA* 0 2 2
Abdominal mass (n=4) 0 0 4 4
Breast lump (n=2) 1 0 2 2
Inguinal lymph node (n=5) 2 0 5 5
Axillary lymph node (n=5) 2 1 5 5
Ileocecal mass (n=5) 0 0 5 5
Soft tissue mass (n=3) 2 2 3 3
Chest wall abscess (n=3) 1 1 3 3
Biopsy
Epididymal mass (n=2) 0 0 2 2
Renal (n=2) NA 0 2 2
Bone (n=3) NA 0 3 3
Breast (n=2) NA 0 2 2
Intestinal (n=4) NA 0 4 4
Axillary lymph node (n=2) 1 1 2 2
*Results not available.
NA indicates not available.
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various cytomorphologic changes such as granulomas
without caseation necrosis, necrotizing granulomas having
variable degrees of necrosis with a few well-organized epi-
theloid cells or giant cells, or tuberculous abscess such as a
large amount of necrotic material with neutrophils, lym-
phocytes, and a few scattered epithelioid cells. Control
specimens showed respective changes as described in Table 1.
Immunostaining and Validation of the Test
Immunostaining with anti-MPT-64 was seen as
reddish brown granular staining in the cytoplasm of
mononuclear cells and multinucleated giant cells (Figs. 1,
2). In caseous necrotic areas of TB lesions, occasional but
strong signals were detected. The staining pattern was
predominantly granular with anti-MPT64, whereas it was
predominantly diffuse with anti-BCG antibodies with a
similar localization.
Results of various tests were compared between the
TB and the non-TB specimens. Positive immunostaining
with anti-MPT64 was seen in all TB specimens and in 1
control specimen, thus yielding a sensitivity of 100% and a
specificity of 97%, whereas anti-BCG was positive in all
TB specimens and in 6/38 (15  7%) control specimens with
a sensitivity of 100% and a specificity of 84%. When a
diagnostic validation of immunostaining was performed
using PCR as the gold standard, the overall sensitivity,
specificity, and positive and negative predictive values for
immunostaining with anti-MPT64 were 100%, 97%, 98%,
and 100%, respectively, and the corresponding values for
anti-BCG were 100%, 84%, 88%, and 100%, respectively.
FIGURE 1. Immunohistochemical staining with anti-MPT64 in tuberculosis lesions from caseating granuloma in the axillary lymph
node (A), noncaseating granuloma from the intestinal wall (B), tuberculous mastitis (C), renal tuberculosis (D), tuber-
culousepidydymitis (E), and tuberculous osteomyelitis (F). Insets show staining in giant cells at a higher magnification.
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An overall comparison showed a significantly (P<0.001)
higher sensitivity of immunostaining with anti-MPT64 as
compared with ZN stain and LJ culture for the diagnosis
of TB without compromising the specificity of the test.
The immunostaining was positive in all granulomas
without necrosis and necrotic material, whereas the ZN
staining was negative in all granulomas and positive in
only 01/12 necrotic material (Table 2).
DISCUSSION
We have previously shown the importance of im-
munostaining using anti-MPT64 for the diagnosis of
EPTB.12–15 In the present study, however, we have shown
that using anti-MPT64 immunostaining, it is possible to
confirm TB with a consistently high sensitivity and spe-
cificity in different suspected TB lesions having equivocal
histology or cytology findings in resource-limited settings
where newer molecular diagnostic or conventional culture
facilities are not available.
The strength of immunostaining using anti-MPT64
is that it is simple, rapid, robust, sensitive, provides clear
and intense signals, makes it possible to differentiate M.
tuberculosis complex infection from atypical mycobac-
teria at early stages of disease, is equally effective for as-
pirates and biopsies, and needs minimum equipment and
technical skill personnel. It can easily be availed in any
clinical pathology laboratory. One of the most important
advantages is that even very tiny specimens are suitable
FIGURE 2. Immunocytochemical staining with anti-MPT64 on cell smears (as shown by arrows) from fine-needle aspirates of
tuberculosis lesions from a breast lump (A), a chest wall abscess (B), a pleural mass (C), and an Abdominal mass (D). Inset shows
strong and granular intracellular staining with anti-MPT64.
TABLE 2. Positive Results of Staining Methods in Various







Necrotic material (n=12) 12 1
Necrosis with granuloma (n=5) 5 3
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for processing, which is extremely important as it is very
difficult to get sufficient specimens from inaccessible EPTB
lesions. Thus, immunostaining with anti-MPT64 should
be a diagnostic procedure in the routine evaluation pro-
tocol of EPTB cases in the surgical pathology laboratory.
Our results show that immunostaining with anti-
MPT64 is much more sensitive than ZN microscopy and
culture.12,13 Although immunostaining is a bit more
technically demanding with extra cost as compared with
ZN staining, the disadvantages are balanced by the sen-
sitivity, the speed, and the ease with which specimens can
be evaluated at a lower magnification (10 or 40)
rather than using oil immersion during microscopy. Also,
immunostaining is significantly faster compared with cul-
ture as the results are available within 1 working day.
Also, this assay has a sensitivity and specificity com-
parable to that of nested-PCR, with the advantage of
being simple, robust, and not sensitive to contamination
and does not require sophisticated equipments, which
make it suitable for implementation in low-income and
middle-income countries with relatively modest laboratory
facilities. These findings warrant the implementation of
this assay in routine TB diagnostic settings in low-income
and lower-middle income countries where an estimated
third of new EPTB cases are missed even with sophisti-
cated technologies such as Xpert MTB/RIF automated
molecular assay for accurate diagnostic assays.17–20 As the
new WHO guidelines on research priorities aim to identify
factors that can enhance the delivery and the im-
plementation of new diagnostics, this assay may be fea-
sible and therefore should be validated at various centers.
The most important advantage of the assay is that we
could confirm granulomatous and necrotic lesions con-
fidently not only on biopsy, but also with cytology material,
which is very important in EPTB cases (Table 2). Our
findings once again proved that the high negative prediction
of anti-MPT64 immunostaining (100%) would help to ex-
clude mycobacterium infection in equivocal lesions (gran-
ulomatous lesions without necrosis), which prevent empiric
anti-TB treatment. The high positive predictive value of
anti-MPT64 (97%) helped us reach an accurate diagnosis,
which is essential in low-endemic countries and in AIDS-
prevalent areas. We previously proved consistently higher
performance indices of the anti-MPT64 antibody on vari-
ous EPTB clinical specimens from different geographical
locations including low-TB and high-TB endemic settings
and HIV samples (Tanzania, India, South Africa, and
Norway).12–15 The assay performed equally well in HIV-
coinfected TB cases with atypical histologic features.14
We overdiagnose 1 control specimen as tuberculous
lesion with anti-MPT64 immunostaining. However, mis-
diagnosis and overdiagnosis were more often observed
with anti-BCG immunostaining. Probably, the lower
specificity with anti-BCG, the only commercially avail-
able antibody for TB, due to cross-reactivity with other
infectious organisms21–23 could be the reason for the re-
straint of immunostaining as the routine assay for the
evaluation of granulomatous lesions in the surgical
pathology laboratory. However, immunostaining with
anti-MPT64 antibodies provides sharp and strong signals
with a clear background compared with anti-BCG anti-
bodies, making interpretation easier and permitting a more
confident diagnosis of M. tuberculosis complex organism.
Because of the low sensitivity of the culture in pauci-ba-
cillary EPTB, we used positive nested-PCR to define TB
cases and for the validation of the immunostaining assay.
All culture-positive cases were positive with nested-PCR
and immunostaining. As the sensitivity and the specificity
of the anti-MPT64 immunostaining assay was very similar
to that of nested-PCR, we once again prove its reliability
for the confirmation of TB in resource-constrained settings.
A further multicenter study with a larger number of
specimens may help decide its use in clinical practice as a
standalone and replacement of the ZN stain test for EPTB
cases.
In conclusion, our study provides the insight for the
feasibility of using the technique as a standalone diagnostic
technique for better management of EPTB patients in
settings where culture or molecular facilities are not
available. We believe that immunostaining using anti-
MPT64 for the identification of M. tuberculosis complex
infection combined with routine cytology/histology and
clinical examination is a sensitive, relatively simple, robust,
and specific technique that can easily be incorporated into
routine pathology laboratories to diagnose EPTB.
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